Cargando…
PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429148/ http://dx.doi.org/10.1097/01.HS9.0000850168.39267.76 |
| _version_ | 1784779346601312256 |
|---|---|
| author | Navickas, A. González, J. Rivas, M. M. Clavijo, M. Carnelutto, N. Funes, M. E. Mela Osorio, M. J. Mariano, R. Rapan, M. L. Moirano, M. Rey, I. Cranco, S. Giunta, J. E. Ramirez, R. Castro, M. B. Enrico, A. Gimenez Conca, A. Belli, C. |
| author_facet | Navickas, A. González, J. Rivas, M. M. Clavijo, M. Carnelutto, N. Funes, M. E. Mela Osorio, M. J. Mariano, R. Rapan, M. L. Moirano, M. Rey, I. Cranco, S. Giunta, J. E. Ramirez, R. Castro, M. B. Enrico, A. Gimenez Conca, A. Belli, C. |
| author_sort | Navickas, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429148 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291482022-08-31 PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS Navickas, A. González, J. Rivas, M. M. Clavijo, M. Carnelutto, N. Funes, M. E. Mela Osorio, M. J. Mariano, R. Rapan, M. L. Moirano, M. Rey, I. Cranco, S. Giunta, J. E. Ramirez, R. Castro, M. B. Enrico, A. Gimenez Conca, A. Belli, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429148/ http://dx.doi.org/10.1097/01.HS9.0000850168.39267.76 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Navickas, A. González, J. Rivas, M. M. Clavijo, M. Carnelutto, N. Funes, M. E. Mela Osorio, M. J. Mariano, R. Rapan, M. L. Moirano, M. Rey, I. Cranco, S. Giunta, J. E. Ramirez, R. Castro, M. B. Enrico, A. Gimenez Conca, A. Belli, C. PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_fullStr | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full_unstemmed | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_short | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_sort | pb1829: argentinean real world experience on midostaurin plus intensive chemotherapy vs intensive chemotherapy to treat flt3 positive acute myeloid leukemia patients |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429148/ http://dx.doi.org/10.1097/01.HS9.0000850168.39267.76 |
| work_keys_str_mv | AT navickasa pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT gonzalezj pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT rivasmm pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT clavijom pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT carnelutton pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT funesme pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT melaosoriomj pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT marianor pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT rapanml pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT moiranom pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT reyi pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT crancos pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT giuntaje pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT ramirezr pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT castromb pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT enricoa pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT gimenezconcaa pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT bellic pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients |